Cas:206055-67-6 1-(2′-O-4-C-Methylene-beta-D-ribofuranosyl)thymine manufacturer & supplier

We serve Chemical Name:1-(2′-O-4-C-Methylene-beta-D-ribofuranosyl)thymine CAS:206055-67-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-(2'-O-4-C-Methylene-beta-D-ribofuranosyl)thymine

Chemical Name:1-(2′-O-4-C-Methylene-beta-D-ribofuranosyl)thymine
CAS.NO:206055-67-6
Synonyms:5-methyl-2′-O,4′-C-methyleneuridine;1-(2′-O-4-C-Methylene-b-D-ribofuranosyl)thymine;(1S,3R,4R,7S)-7-hydroxy-1-hydroxymethyl-3-(thymin-1-yl)-2,5-dioxabicyclo[2.2.1]heptane;(1S,3R,4R,7S)-7-hydroxy-1-hydroxymethyl-(thymin-1-yl)-2,5-dioxabicyclo[2.2.1]heptane;2′-O,4′-C-methylenethymidine;2′-O,4′-C-methylene-5-methyluridine
Molecular Formula:C11H14N2O6
Molecular Weight:270.23900
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.598
Index of Refraction:
PSA:113.78000
Exact Mass:270.08500
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-methyl-2′-O,4′-C-methyleneuridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2′-O,4′-C-methylene-5-methyluridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2′-O,4′-C-methylene-5-methyluridine Use and application,1-(2′-O-4-C-Methylene-b-D-ribofuranosyl)thymine technical grade,usp/ep/jp grade.


Related News: EMA said the drug can help improve the respiratory function of Pompe disease patients, and the most common side effects include hypersensitivity (including anaphylaxis) and infusion-associated reactions. (1R)-N,N-diethyl-3,3-dimethyl-2-methylene-1-bicyclo[2.2.1]heptanesulfenamide manufacturers Officials did, however, acknowledge that there’s growing evidence an extra jab may enhance the antibody response in immunocompromised people. Some small studies suggest up to 50% of people with no antibody response after the authorized regimen of two mRNA jabs developed a response after an additional dose, said CDC’s Sara Oliver, M.D. 3-Ethylsulfinyl-5-(2-methyl-3-(dimethylamino)-propyl)-10,11-dihydro-5H-dibenz(b,f)azepin-oxalat suppliers The inhaled version was also found to trigger neutralising antibodies and T cell responses after one dose. Nb(η(5)-C5H4SiMe3)2(CO)(η(1)-OC(H)NPh) vendor & factory.